The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective

Angiogenesis is a crucial process for organ morphogenesis and growth during development, and it is especially relevant during the repair of wounded tissue in adults. It is coordinated by an equilibrium of pro- and anti-angiogenic factors; nevertheless, when affected, it promotes several diseases. La...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 9; p. 1091
Main Authors Hernández-Romero, Itzel Alejandra, Guerra-Calderas, Lissania, Salgado-Albarrán, Marisol, Maldonado-Huerta, Tatiana, Soto-Reyes, Ernesto
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 24.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Angiogenesis is a crucial process for organ morphogenesis and growth during development, and it is especially relevant during the repair of wounded tissue in adults. It is coordinated by an equilibrium of pro- and anti-angiogenic factors; nevertheless, when affected, it promotes several diseases. Lately, a growing body of evidence is indicating that non-coding RNAs (ncRNAs), such as miRNAs, circRNAs, and lncRNAs, play critical roles in angiogenesis. These ncRNAs can act in cis or trans and alter gene transcription by several mechanisms including epigenetic processes. In the following pages, we will discuss the functions of ncRNAs in the regulation of angiogenesis and neovascularization, both in normal and disease contexts, from an epigenetic perspective. Additionally, we will describe the contribution of Next-Generation Sequencing (NGS) techniques to the discovery and understanding of the role of ncRNAs in angiogenesis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Fahd Al-Mulla, Genatak, Kuwait; Shao-Chun Wang, China Medical University, Taiwan
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work
Edited by: Erika Ruiz-Garcia, National Institute of Cancerology (INCan), Mexico
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2019.01091